Optimizing medication regimes for seniors by FORTA: a prospective, randomized multi-center study in primary care (Fit FOR The Aged)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00009236

Enrollment

484

Registered

2015-10-30

Start date

2016-09-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication quality: overuse, underuse R54 R29.6

Interventions

Group 1: Education of primary care physicians on the FORTA-Classification (Fit fOR The Aged): Physicians will be educated on the appropriateness of medication for seniors according to FORTA. Using cli

Eligibility

Sex/Gender

All

Age

70 Years to No maximum

Inclusion criteria

Inclusion criteria: = 5 long-term medication that was prescriped by the primary care physician in charge, sufficient language skills and cognitive abilities to answer a questionnaire and to participate in the clinical examination. Subjects were patients of the respective primary care practice during the previous three months.

Exclusion criteria

Exclusion criteria: Patients with malignant disease (chemotherapy and/or radiation), HIV/AIDS, dialysis-dependent kidney diseases, transplanted patients, dementia, life expectancy of less than 12 months according to medical opinion

Design outcomes

Primary

Measure	Time frame
Difference in medication quality between intervention and control arm, measured with the FORTA-score, 9 months after the intervention	—

Secondary

Measure	Time frame
1) FORTA-sub-scores for under use and over use 2) Geriatric assessment (mobility/risk of falling, cognitive abilities, activities of daily living) (clinical examination at baseline & follow-up) 3) Blood pressure (sitting and standing) (clinical examination at baseline & follow-up) 4) Physicians' assessment of medication adherence (questionnaire at baseline) 5) Subjective well-being (questionnaire at baseline & follow-up) 6) Pain (questionnaire at baseline & follow-up) 7) Incident diagnosis (case record form at follow-up) 8) Incident adverse drug events (case record form at follow-up) 9) Incident falls, related health outcomes including hospital admissions (case record form at follow-up) 10) Hospital admissions, any cause; Number of days in hospital (case record form at follow-up) 11) Admission to nursing homes (case record form at follow-up) 10) All cause death (case record form at follow-up)	—

Measure

Time frame

1) FORTA-sub-scores for under use and over use 2) Geriatric assessment (mobility/risk of falling, cognitive abilities, activities of daily living) (clinical examination at baseline & follow-up) 3) Blood pressure (sitting and standing) (clinical examination at baseline & follow-up) 4) Physicians' assessment of medication adherence (questionnaire at baseline) 5) Subjective well-being (questionnaire at baseline & follow-up) 6) Pain (questionnaire at baseline & follow-up) 7) Incident diagnosis (case record form at follow-up) 8) Incident adverse drug events (case record form at follow-up) 9) Incident falls, related health outcomes including hospital admissions (case record form at follow-up) 10) Hospital admissions, any cause; Number of days in hospital (case record form at follow-up) 11) Admission to nursing homes (case record form at follow-up) 10) All cause death (case record form at follow-up)

—

Countries

Germany

Contacts

Public ContactBirgitta Weltermann

Institut für Allgemeinmedizin, Universitätsklinikum Essen, Universität Duisburg-Essen

birgitta.weltermann@uk-essen.de0201-877 869-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026